Viatris Inc. (VTRS) is a global healthcare powerhouse dedicated to expanding access to high-quality medicines and helping people live healthier lives at every stage. Leveraging a diverse portfolio that spans generics, established brands, and innovative therapies, the company addresses a wide range of healthcare needs, including areas with significant unmet demand. Backed by a global footprint, Viatris combines scale, innovation, and supply-chain resilience to deliver sustainable healthcare solutions to patients worldwide.
With a market value of roughly $17.89 billion, Viatris comfortably qualifies as a large-cap stock. Its sizable valuation not only exceeds the $10 billion benchmark for large-cap companies but also underscores its established presence and scale within the healthcare space. Viatris has emerged as a standout performer on Wall Street, delivering returns that have handily outpaced the broader healthcare industry.
